COVID-19: Clinical Resources & Patient Education
Updated June 25, 2021
Interim Guidance for Clinical Management
- Evaluating and Caring for Patients with Post-COVID Conditions: Interim Guidance: How to manage a wide range of physical and mental health consequences experienced by some patients four or more weeks after SARS-CoV-2 infection. (6/14/21)
- Updated NIH COVID-19 Treatment Guidelines: Each recommendation is assigned a rating for strength of recommendation statement and quality of the evidence that supports the recommendation. (2/11/21)
- Management of COVID-19 at Home: View a webcast on current recommendations for advising patients on managing mild to moderate COVID-19 at home and when to escalate care. (1/22/21)
- Outpatient Management of COVID-19: Rapid Evidence Review: AFP addresses the lack of evidence-based treatments for outpatient settings; management is supportive and should include education about isolation.
- Updated Interim Guidance for Clinical Management of Patients with COVID-19 (12/8/20)
- Reinfection with COVID-19 Reports: There have been some reports of reinfection, but these are rare. The CDC is monitoring these cases and develop criteria and guidance for potential cases of reinfection. (10/27/20)
Options for Treatment
- ASPR Issues National Pause: COVID-19 Variants and Effect on Monoclonal Antibody Therapeutics Distribution: Results suggest that bamlanivimab and etesevimab administered together are not active against either the increasing number of P.1 or B.1.351 variants. (6/25/21)
- Updated NIH COVID-19 Treatment Guidelines: New recommendations covering monoclonal antibodies in the outpatient setting and use of barcitinib for certain patients who are hospitalized with COVID-19. (6/11/21)
- Monoclonal Antibodies Authorized for COVID-19: The FDA has issued an Emergency Use Authorization (EUA) for several monoclonal antibody treatments for COVID-19. View a brief overview of the EUAs. (2/9/21)
- AAFP Policy on COVID-19 Therapeutics: The AAFP cautions against prescribing therapeutics for treatment or prevention of COVID-19 that have not been approved or authorized by the FDA. (11/11/20)
- FDA Revokes EUA for Hydroxychloroquine for Treatment of COVID-19: It has not shown efficacy in its antiviral activity. Data do not support that the benefits outweigh the harms of the drug. (6/15/20)
- Evidence lacking to support use of ivermectin for COVID-19: There are insufficient data to recommend either for or against the use of ivermectin for the treatment of COVID-19. (1/14/21)
- First Treatment Approved for COVID-19: FDA approved the use of remdesivir for patients who have COVID-19 and are hospitalized. (10/22/20)
Testing and Diagnosis
- AAFP COVID-19 Testing Resources Web Page: This web page provides information on who to test, access and availability, types of tests, results, impact of new variants, specimen collection, and coding and billing. (Updated 4/20/21)
Considerations for Special Populations
- Updated! AAFP Considerations for Pregnancy, Breastfeeding and COVID-19: The AAFP recommends promotion of breastfeeding and parent-infant bonding, and avoidance of parent-infant separation. (2/17/21) The AAFP offers additional breastfeeding resources to support your patients.
- Guidance for Children/Adolescents (12/8/20)
- Updated Guidance for Care of Neonates (12/8/20)
- Communication Toolkit for Migrants, Refugees, and Other Limited-English-Proficient Populations: A CDC resource for public health professionals to reach populations who need COVID-19 prevention messaging in their native languages. (6/15/20)
- Patient-Centered Care for Pregnant Patients during the COVID-19 Pandemic: This joint statement affirms that licensed and accredited hospitals and birth centers will take precautions to remain safe places to give birth. (3/30/20)
- AAFP Smoking Cessation Resources for Family Physicians: Tobacco users are more likely to have COVID-19 progression, requiring more extensive treatment and hospitalization. Start the conversation with your patients and use these tools to help them cut their risk. (4/15/20)
- CDC Guidance on Reopening Schools: Family physicians should closely monitor plans to reopen schools in their area and continue promoting routine vaccinations for school-age children to prevent other disease outbreaks. (8/21/20)
Infection Control/Emergency Preparedness
- Interim Public Health Recommendations for Fully Vaccinated People: This guidance provides recommendations for fully vaccinated people.
- Updated Healthcare Infection Prevention and Control Recommendations After Vaccination: CDC has updated select healthcare infection prevention and control recommendation. (4/27/21)
- Quarantine Guidance Updates: View the updated guidance for quarantining and definitions for close-contact. (2/11/21)
- Guidance for Risk Assessment and Public Health Management of Healthcare Personnel with Potential Exposure in Healthcare Setting (2/11/21)
- Healthcare Emergency Preparedness Information Gateway: This resource from HHS, which includes COVID-19 information, offers technical assistance on health emergency preparedness to health care organizations and physicians. (2/11/21)
- Strategies for Optimizing the Supply of PPE: Guidance on prioritizing and reusing. (2/11/21)
- Frequently Asked Questions and Answers for COVID-19: Key information for patients and health care professionals. (2/11/21)
- Preparedness Resources for Hospitals and Healthcare Professionals: Two checklists identify preparedness actions that can be taken now. (2/11/21)
- Preparing for COVID-19: Long-term Care Facilities, Nursing Homes (2/11/21)
- Travel: Frequently Asked Questions and Answers (2/11/21)
Patient Education
- COVID-19 Vaccine
- COVID-19 Vaccine Frequently Asked Questions
- Video: How To (Not) to Wear a Mask
- Video: Family Physicians are Writing Americans a Prescription to Stay Home
- About COVID-19: Includes patient fact sheets.
- Communication Resources from CDC: Materials to help communicate to patients.
- Beware of Fraudulent Coronavirus Tests, Vaccines and Treatments
- Do I Have COVID-19 or the Flu?
- COVID-19 Testing